Please login to the form below

Not currently logged in
Email:
Password:

apremilast

This page shows the latest apremilast news and features for those working in and with pharma, biotech and healthcare.

AbbVie, Amgen and Takeda team up for joint COVID-19 trial

AbbVie, Amgen and Takeda team up for joint COVID-19 trial

19. The I-SPY COVID-19 trial will evaluate the safety and efficacy of AbbVie’s experimental CCR2 and CCR5 inhibitor cenicriviroc, Amgen’s psoriasis treatment Otezla (apremilast) and Takeda’s

Latest news

More from news
Approximately 5 fully matching, plus 28 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Infographic: RA Perceptions

    The greatest levels of familiarity and interest were reported for novel small molecules such as Celgene’s Otezla (apremilast) and Pfizer’s Xeljanz (tofacitinib), which both offer a new oral alternative

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics